Not all clients with CLL need therapy. Regardless of all recent improvements, the iwCLL nonetheless recommends watchful observation for patients with asymptomatic disease.86 This advice relies on at the least two randomized trials comparing observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). Partisipasi aktif dari masyarakat dalam https://malcolmn534gtc9.blogpayz.com/profile